China's critically ill, and well-heeled, add twist to outgoing medical tourism
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Beijing
CHINA'S medical system could not stop the cancer eating at Guo Shushi's stomach. It roared back even after Mr Guo, a 63-year-old real estate developer, endured surgery, chemotherapy and radiation at two hospitals.
Then his son-in-law discovered online that - for a price - companies were willing to help critically ill Chinese people seek treatment abroad. Soon Mr Guo was at the Dana-Farber Cancer Institute in Boston, receiving a new immunotherapy drug, Keytruda, which is not available in China. In April, nearly four months later, his tumour has shrunk and his weight has gone up.
Share with us your feedback on BT's products and services